Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05838729
Status:
RECRUITING
Last Update Posted:
2023-12-18
First Post:
2023-04-13
Brief Title:
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
Sponsor:
Coordination Pharmaceuticals Inc
Organization:
Coordination Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head Neck Cancer |
| Intratumoral Injection |
Keywords: